Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Every… (NCT07745816) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'
Singapore300 participantsStarted 2026-08-01
Plain-language summary
Advanced cancer patients often experience significant physical and emotional symptoms, which can lead to frequent hospital visits and reduced quality of life. Although palliative care can help manage these symptoms and improve well-being, it is often introduced too late.
A proactive symptom monitoring model, SPARKLE-2 aims to identify patients who need palliative care earlier by regularly checking their symptoms using a simple questionnaire. Patients with concerned symptoms will receive timely support from the palliative care team, with the goal of improving their quality of life, reducing unnecessary hospital admissions, and helping more patients receive care in the community rather than in hospital. In the earlier SPARKLE-1 study, it showed the improvement of patients' physical wellbeing. SPARKLE-2 seeks to test the effectiveness among advanced cancer patients with unplanned hospital visits while simultaneously collecting data on real-world implementation.
Who can participate
Age range
21 Years – 120 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. 21 years old or older
. Diagnosed of advanced cancer diagnosis, defined as metastatic or recurrent/ progressive Stage III/IV solid tumour
. Has an unplanned hospital admission and expected to be discharged home
. Able to speak English or Mandarin Chinese or Malay
. Able to provide informed consent
. Enrolled in the SPARKLE-2 RCT, whether randomized to the SPARKLE intervention or usual care group and regardless of fidelity to trial procedures.
. 21 years old or older
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on palliative and supportive care for people with cancer — does that mean it's about improving quality of life and symptom management rather than treating the cancer itself, and how would that fit alongside my current or planned treatment?
2The trial hasn't started recruiting yet — do you know when it's expected to open, and is there a way to get on a list so we can revisit this once enrollment begins?
3The study is measuring quality of life using a specific tool called the FACIT-Pal — can you explain what that involves in terms of assessments or check-ins, and how much of a time commitment it would realistically be for me?
4Since this is a 'Phase NA' study focused on implementing a care review process, what exactly would change about how my care is delivered if I were to participate, and are there any risks or downsides I should be aware of?
5Would standard palliative or supportive care offered here at your practice cover the same ground as what this trial is testing, or is there a reason this structured 'kit' approach might offer something different worth waiting for?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Quality of life score measured using the Functional Assessment of Chronic Illness Therapy - Palliative (FACIT-Pal)
. Self-endorsing or identified by an enrolled patient as a spouse/partner, relative or friend who knows them well and who provides support due to their cancer
Exclusion criteria
. Assessed by the treating physician as unable to complete study procedures
. Unable to complete patient-reported outcome measures
. Healthcare professionals that are not providing care for cancer patients.